Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $85.90 | $23.61 | 263.86% | 186.74x | 143.96x | 11.66x | 14.45x | 1.33x | $119.79M | 1.34% | $637.99M | 6.11 | $9.12B | -1,328.63 | ||
| LQDA | LIQUIDIA CORP | $71.21 | $17.27 | 312.41% | 296.71x | 20.73x | 21.76x | 58.32x | 1.46x | $41.15M | 0.66% | $108.58M | 1.23 | $6.29B | 117.44 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.16 | $2.76 | 195.63% | 116.57x | 71.64x | 4.42x | 108.27x | 1.12x | $47.52M | 3.42% | $13.01M | 0.08 | $1.56B | 29.11 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $288.06 | $91.13 | 216.10% | 66.07x | 38.46x | 8.93x | 35.76x | 1.38x | $641.34M | 1.68% | $1.08B | 8.09 | $39.72B | 42.96 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $60.94 | $16.92 | 260.22% | 62.18x | 47.73x | 6.18x | 7.74x | 1.68x | $164.23M | 3.52% | $605.69M | 7.92 | $4.51B | 40.43 | ||
| KRYS | KRYSTAL BIOTECH INC | $363.44 | $93.15 | 290.15% | 46.90x | 46.43x | 25.51x | 8.39x | 2.24x | $237.38M | 2.23% | $1.28B | 43.59 | $10.22B | 47.78 | ||
| VCEL | VERICEL CORP | $47.49 | $8.92 | 432.20% | 110.44x | 98.51x | 8.25x | 6.81x | 2.32x | $47.49M | 1.97% | $356.23M | 7.02 | $2.41B | 59.64 | ||
| HALO | HALOZYME THERAPEUTICS INC | $76.11 | $69.66 | 9.25% | 25.71x | 9.16x | 5.96x | 41.10x | 0.46x | $667.65M | 7.42% | $219.64M | 1.86 | $10.86B | 17.41 | ||
| RPRX | ROYALTY PHARMA PLC | $56.45 | $38.95 | 44.92% | 29.55x | 10.58x | 10.10x | 3.27x | 0.64x | $2.34B | 9.49% | $9.94B | 22.75 | $40.88B | 35.13 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $59.20 | $39.41 | 50.20% | 42.29x | 16.02x | 3.51x | 1.84x | 0.60x | $767.06M | 6.73% | $6.21B | 32.27 | $9.80B | 20.31 | ||
| ADMA | ADMA BIOLOGICS INC | $8.97 | $8.99 | -0.19% | 13.00x | 10.69x | 4.15x | 5.33x | 0.54x | $107.90M | 5.09% | $390.33M | 1.65 | $2.14B | 9.65 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $236.97 | $48.00 | 393.64% | 504.19x | 9.16x | 3.30x | 3.28x | 1.71x | $1.30B | 8.85% | $4.53B | 73.22 | $18.43B | 27.30 | ||
| ASND | ASCENDIS PHARMA A | $265.22 | $78.98 | 235.81% | 28.11x | 18.06x | 16.17x | 28.69x | 2.86x | $52.94M | 0.32% | $574.09M | 9.24 | $16.85B | 180.73 | ||
| TGTX | TG THERAPEUTICS INC | $55.01 | $20.35 | 170.30% | 17.08x | 39.58x | 11.34x | 14.44x | 4.78x | -$14.19M | -0.18% | $583.13M | 4.04 | $8.73B | 58.19 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $309.25 | $92.17 | 235.50% | 39.15x | 34.07x | 22.40x | 6.21x | 1.97x | $122.22M | 1.99% | $997.32M | 50.16 | $6.53B | 28.97 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $35.54 | $34.98 | 1.60% | 14.05x | 9.74x | 2.29x | 2.26x | 0.53x | $341.79M | 16.63% | $910.35M | 15.75 | $1.63B | 6.87 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.18 | $8.77 | -75.14% | 8.07x | -7.37x | 2.04x | 2.38x | 0.10x | $7.24M | 5.78% | $52.93M | 0.92 | $72.57M | 4.68 | ||
| TECH | BIO-TECHNE CORP | $71.36 | $16.36 | 336.20% | 100.51x | 34.20x | 9.21x | 5.36x | 1.84x | $269.60M | 2.42% | $2.09B | 13.34 | $11.25B | 43.96 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $480.25 | $164.02 | 192.81% | 28.23x | 24.57x | 9.99x | 6.30x | 2.06x | $3.71B | 3.04% | $19.36B | 76.20 | $118.38B | 21.95 | ||
| UTHR | UNITED THERAPEUTICS CORP | $535.57 | $236.14 | 126.81% | 18.29x | 19.28x | 7.35x | 3.85x | 2.06x | $1.02B | 4.36% | $5.90B | 135.66 | $21.45B | 12.52 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.47 | $2.40 | 44.45% | 14.46x | 14.67x | 2.13x | 3.36x | 0.98x | $4.11M | 1.47% | $82.33M | 1.03 | $212.39M | 10.00 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.48 | $12.49 | 152.07% | 17.39x | 15.80x | 6.45x | 3.80x | 3.25x | $208.13M | 5.41% | $1.01B | 8.28 | $3.10B | 9.25 | ||
| EXEL | EXELIXIS INC | $56.04 | $30.37 | 84.54% | 17.96x | 17.22x | 6.09x | 7.28x | 1.29x | $917.69M | 6.34% | $1.94B | 7.49 | $14.03B | 13.29 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $663.09 | $425.66 | 55.78% | 15.58x | 14.09x | 4.62x | 2.21x | 1.05x | $4.11B | 5.96% | $31.42B | 302.15 | $69.26B | 12.06 | ||
| VCYT | VERACYTE INC | $57.48 | $7.44 | 672.84% | 51.78x | 51.84x | 8.44x | 3.41x | 10.93x | $155.34M | 3.40% | $1.34B | 16.90 | $4.36B | 37.91 | ||
| INCY | INCYTE CORP | $114.23 | $63.41 | 80.15% | 15.67x | 14.43x | 4.25x | 4.06x | 1.45x | $1.45B | 6.37% | $5.62B | 28.21 | $19.39B | 10.36 | ||
| MDXG | MIMEDX GROUP INC | $4.08 | $1.21 | 236.75% | 19.43x | -48.46x | 1.56x | 2.50x | 10.23x | $69.36M | 11.45% | $242.94M | 1.64 | $465.52M | 8.55 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $18.82 | $3.18 | 492.55% | 31.37x | 5.14x | 0.90x | 1.32x | 69.89x | $109.24M | 5.53% | $1.51B | 14.34 | $2.56B | 30.93 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.